Article info
PDFLetter
Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries
- Correspondence to Dr Johan Askling, Clinical Epidemiology Unit T2:01, Department of Medicine, Karolinska University Hospital Solna, Stockholm SE-171 76, Sweden; Johan.askling{at}ki.se
Citation
Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries
Publication history
- Received June 10, 2013
- Revised July 29, 2013
- Accepted September 8, 2013
- First published September 20, 2013.
Online issue publication
October 31, 2019
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions